NO20052957L - Chorionisk somatomammotropin hormon spleisevarianter - Google Patents

Chorionisk somatomammotropin hormon spleisevarianter

Info

Publication number
NO20052957L
NO20052957L NO20052957A NO20052957A NO20052957L NO 20052957 L NO20052957 L NO 20052957L NO 20052957 A NO20052957 A NO 20052957A NO 20052957 A NO20052957 A NO 20052957A NO 20052957 L NO20052957 L NO 20052957L
Authority
NO
Norway
Prior art keywords
chorionic somatomammotropin
splice variants
somatomammotropin hormone
hormone
chorionic
Prior art date
Application number
NO20052957A
Other languages
English (en)
Other versions
NO20052957D0 (no
Inventor
Richard Joseph Fagan
Christopher Benjamin Phelps
Tania Rodrigues
Melanie Yorke
Mariastella De Tiani
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20052957D0 publication Critical patent/NO20052957D0/no
Publication of NO20052957L publication Critical patent/NO20052957L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57518—Placental lactogen; Chorionic somatomammotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

SAMMENDRAG Oppfinnelsen er basert på oppdagelsen at INSP 100 er en ny spleisevariant av humant korionisk somatomammotropinhormon 2 (hCS-B; Q 14407) og at INSP 104 er en ny spleisevariant av humant korionisk somatomammotropinhormon 1 (hCS-A; P01243).
NO20052957A 2002-12-20 2005-06-16 Chorionisk somatomammotropin hormon spleisevarianter NO20052957L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0229856.0A GB0229856D0 (en) 2002-12-20 2002-12-20 Splice variant
PCT/GB2003/005605 WO2004056860A2 (en) 2002-12-20 2003-12-22 Chorionic somatomammotropin hormone splice variants

Publications (2)

Publication Number Publication Date
NO20052957D0 NO20052957D0 (no) 2005-06-16
NO20052957L true NO20052957L (no) 2005-08-25

Family

ID=9950192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052957A NO20052957L (no) 2002-12-20 2005-06-16 Chorionisk somatomammotropin hormon spleisevarianter

Country Status (9)

Country Link
US (1) US20070032416A1 (no)
EP (1) EP1578796A2 (no)
JP (1) JP2006526385A (no)
AU (1) AU2003290310A1 (no)
CA (1) CA2511777A1 (no)
GB (1) GB0229856D0 (no)
IL (1) IL169185A0 (no)
NO (1) NO20052957L (no)
WO (1) WO2004056860A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113533707B (zh) * 2021-07-13 2024-05-28 重庆德方信息技术有限公司 尿液检测卡自动装配装置

Also Published As

Publication number Publication date
NO20052957D0 (no) 2005-06-16
US20070032416A1 (en) 2007-02-08
CA2511777A1 (en) 2004-07-08
GB0229856D0 (en) 2003-01-29
WO2004056860A2 (en) 2004-07-08
AU2003290310A1 (en) 2004-07-14
IL169185A0 (en) 2007-07-04
WO2004056860A3 (en) 2005-01-13
EP1578796A2 (en) 2005-09-28
JP2006526385A (ja) 2006-11-24

Similar Documents

Publication Publication Date Title
DE60141842D1 (de) Erosklerose
EP1578771A4 (en) REMODELING AND GLYCOKON JUGATION OF PEPTIDES
CY1109068T1 (el) Υποκατεστημενες πυριδινυλαμινες
EP1006386A4 (en) CLEARANCE KNIVES AND CAMERA
EP1404161A4 (en) IGNITION DEVICE FOR A DISCHARGE LAMP AND PROJECTOR DEVICE
DE60011166D1 (de) Elektronenemittierendes Element und Bildausgabevorrichtung
ATE390629T1 (de) Mikrophysiomessgerät
NO994906L (no) GnRH antagonister som er modifisert i stillinger 5 og 6
EP1578971A4 (en) STRESS-RELATED POLYPEPTIDES AND ITS USES
ATE259512T1 (de) Tragbares telefon und einschaltverfahren
NO20002479L (no) Kombinasjon av angiotensinkonverterende enzyminhibitor og et diuretikum for behandling av mikrosirkulatoriske forstyrrelser
IT1306560B1 (it) Dispositivo di regolazione e limitazione della miscela percarburatore.
ITMI20021822A1 (it) Manicotto elastico e procedimento per la fabbricazione di un manicotto elastico
EE200300339A (et) Helicobacter pylory uudsed retseptorid ja nende kasutamine
JO2369B1 (en) Novel cyclohexyl sulphones
SE0102834D0 (sv) Anordning vid en fingerprotes
EP1096197A3 (en) Light source device and projector utilizing the same
NO20000383D0 (no) Forlengingsroersammenstilling og fremgangsmåte til å sette samme
DK1208113T3 (da) 17beta-acyl-17alfa-propynyl-11beta-(cycloamino)arylsterioder og afledte heraf med hormonantagonistiske egenskaber
NO20021012L (no) Reflektor og LCD-anordning av refleksjonstype som utnytter denne
EP1350509A4 (en) MUCOSAL IMMUNOMODULATOR AND ITS USE
ITMI20021103A0 (it) Soffietto con un'estremita' libera
NO995300L (no) Anvendelse av 1-ar(alk)yl-imidazolin-2-on for behandling av angst- og spenningstilstander
WO2004056860A3 (en) Chorionic somatomammotropin hormone splice variants
EP1406921A4 (en) HYPOGLYCAEMIC PEPTIDES AND METHOD FOR USE THEREOF

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application